Financials
Financial year 2025
Worth noting
- Figures corrected afterwards (2024).
Revenue
€ 85.5 million
▲ 10% vs 2024
Profit
Healthy€ 33,849
▼ 99% vs 2024
Debts
Normal€ 27.5 million
▲ 55% vs 2024
ABBOTT MEDICAL BELGIUM from Zaventem, company number BE0441665942, closed financial year 2025 with a result of € 33,849 after tax. For that financial year ABBOTT MEDICAL BELGIUM recorded revenue of € 85.5 million and equity of € 13.3 million. Compared with financial year 2024, the result moved from € 3.7 million to € 33,849. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 3, 2026.
What happened at ABBOTT MEDICAL BELGIUM?
What happened at ABBOTT MEDICAL BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Tim Demaerschalk stepped down as director. NBB
- Bradley Jay Slater stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 33,849 (▼ 99% vs 2024). Source: NBB ↗
- Tim Demaerschalk became a director. NBB
- Bradley Jay Slater became a director. NBB
- New establishment in Machelen (Brab.). KBO
- New establishment in Zaventem. KBO
- Start of the company according to the CBE. KBO
In short
From € 1.1 million profit in 2021 to € 33,849 profit in 2025.
Paid € 3.7 million in corporate taxes since 2021.
Best year ever: 2024, with € 3.7 million profit.
Pays suppliers within 48 days on average.
A new publication or filing at ABBOTT MEDICAL BELGIUM? We notify you, reason included.
Follow ABBOTT MEDICAL BELGIUMNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by Abbott SA (100%) and St Jude Medical LLC (0%).
Directors
According to the 2025 annual accounts
Bradley Jay Slater
Director
since 2022 · until 2029
Tim Demaerschalk
Director
since 2026 · until 2032
Shareholders
100%
St Jude Medical LLC
0%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Da Vincilaan 11 box F1
1930 Zaventem
Culliganlaan 2 box B
1831 Machelen (Brab.)
Active since 1 January 2019
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
Abbott Belgian Pension Fund
Abbott Rapid Diagnostics
€ 7.9 million revenue · 2025
GARTNER BELGIUM
€ 54.2 million revenue · 2025
TMC Science & Technology
€ 41.8 million revenue · 2025
OPEN PIXEL SYSTEMS
€ 449,625 gross margin · 2025
+1 more
Details
- Company number
- 0441.665.942
- VAT number
- BE 0441.665.942
- Registered office
- Da Vincilaan 11 bus F1, 1930 Zaventem
- Names & denominations
- ABBOTT MEDICAL BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 28 September 1990
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten